Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US14070B3096
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000DZMK99
CAPR
Capricor Therapeutics, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Capricor Therapeutics, Inc.
ISIN
US14070B3096
TICKER
CAPR
MIC
XNAS
REUTERS
CAPR.OQ
BLOOMBERG
CAPR US
Sat, 19.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 18.09.2026       Capricor Therapeutics
US14070B3096

San Diego, California--(Newsfile Corp. - September 18, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period"), have until Monday, September 28, 2026 to seek appointment as lead...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 18.09.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - September 18, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with a premier securities practice group-notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This al...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 18.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Capricor to Contact Him Directly to Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 17, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors of the September 28, 2026 dead...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.09.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - September 17, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through J...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.09.2026       Capricor Therapeutics
US14070B3096

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ:CAPR) and certain of the company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.If you invested in C...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 16.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 15.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 15, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 14.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 13.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 11.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 11, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 11.09.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - September 11, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with a premier securities practice group-notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This al...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 11.09.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - September 11, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through J...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 10.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 10.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 09.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 9, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 09.09.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - September 9, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through Ju...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 09.09.2026       Capricor Therapeutics
US14070B3096

The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares in the U.S. District Court for Southern District of California (No: 3:26-cv-04385). Investors, who purchased a significant amount of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 a...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Wed, 09.09.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - September 8, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with a premier securities practice group-notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This ale...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 08.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 08.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 07.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 07.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 06.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sat, 05.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sat, 05.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If yo...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 04.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 04.09.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - September 4, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with a premier securities practice group-notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the upcoming September 28, 2026 lead plaintiff deadline in the ongoing securities class action. This ale...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 04.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If yo...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 3, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you pur...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 03.09.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - September 2, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: Th...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Capricor Therapeutics
US14070B3096

San Diego, California--(Newsfile Corp. - September 2, 2026) - Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period"). The lawsuit alleg...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - September 2, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through Ju...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 02.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If yo...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - September 1, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - September 1, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through Ju...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purch...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 01.09.2026       Capricor Therapeutics
US14070B3096

San Diego, California--(Newsfile Corp. - August 31, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period"), have until Monday, September 28, 2026 to seek appoint...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 31, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 31.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purch...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 28.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 28, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 28.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Read more
Capricor Therapeutics
Technical Analysis Termsheets Terminal
Permalink